Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
The current price of Merck & Co Inc in the market is 111,4 €, with a 24-hour trading volume of 575,22M €. The asset's market cap is 275,15B €, after moving 0.96% in the last day.
Tokenized Merck & Co Inc is trading at 111,4 €, with a tokenized market cap of 36,83M € and a 24-hour trading volume of 582,57K €. The tokenized asset has moved 4.20% in the past 24 hours.